Science, Scientific Research, Rare Disease.
treatments for HIV demonstrates the effectiveness of this strategy. “With a common disease, you have enough patients” to run both biomarkers and clinical endpoints, Kakkis said. “With rare diseases, you’re stuck.” Many Complex Angles Nothing in the world of rare disease is “one size fits all.” Some